Delivery Order SPE2DB20D1100-SPE2DB24FA1Y9

Award Date 2/12/24
Potential Completion Date 2/13/24
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order worth $1,187.55 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, with a completion date of February 12, 2024. This delivery order falls under Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA,...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $2,686.94 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. This is a one-time order with a completion date of June 26, 2024. The award is not associated with a larger contract vehicle. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S....
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,046.28 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to AmerisourceBergen Drug Corp as the sole prime contractor. The IDC, which does not fall under any overarching...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract worth $1,410.37 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. This contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has a performance period through March 6, 2024. AmerisourceBergen Drug Corp, operating out of its Corporate Office division in Conshohocken,...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $1,005.88 to Amerisourcebergen Drug Corp for the provision of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. This delivery order has a completion date of February 29, 2024. Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, is the prime contractor for this award. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp also holds an...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The contract has a ceiling value of $1,022.38 and a performance period through April 1, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through...
The U.S. Defense Logistics Agency (DLA) awarded a $2,798.52 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of XULANE 150-35 MCG/DAY PATCH 3S. This order falls under Amerisourcebergen's $999,999,999.00 single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of pharmaceutical products and medical supplies for...
The U.S. Defense Logistics Agency (DLA) awarded a $1,582.93 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of XULANE 150-35 MCG/DAY PATCH 3S. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as AmerisourceBergen, with the DLA Troop Support Medical. The IDC, which runs through November 2026, enables...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, with a potential value of $1,626.15 and a completion date of January 31, 2024. This award is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The award is a delivery order valued at $1,187.55 for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has an ultimate completion date of March 27, 2024 and is a firm fixed price delivery order. Amerisourcebergen Drug Corp, through its...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FA1Y9
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,456.52 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, with a completion date of February 13, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this award.

Generated 5/13/24, 9:41 AM